Lithium Ion

Lithium Ion

SCHEMBL4370616

O=C([O-])C(CS)C1CC1.O=C([O-])C(CS)C1CC1.[Li+].[Li+]

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CPN1 P15169 6/20 0.47
CPB2 Q96IY4 6/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29972171 0.95 CPN1 (0.47) CPN1CPB2
SCHEMBL989518 0.76
SCHEMBL2079843 0.74 CPN1 (0.70) CPN1CPB2
SCHEMBL9063708 0.74
SCHEMBL11147752 0.71 TSHR (0.38) CPN1CPB2
Lithium Ion SCHEMBL3888071 0.68 SHBG (0.45)
SCHEMBL5982259 0.68 CPB2 (0.44) CPN1CPB2
SCHEMBL25389365 0.68 CPN1 (0.68) CPN1CPB2
SCHEMBL6435945 0.64 SHBG (0.45)
SCHEMBL7630887 0.64 SHBG (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114889-A1 METHOD OF PREPARING MONTELUKAST AND INTERMEDIATES USED THEREIN Hanmi Pharm. Co., Ltd. (KR) 2009-11-11 EP disclosed
WO-2008072872-A1 METHOD OF PREPARING MONTELUKAST AND INTERMEDIATES USED THEREIN HANMI PHARM. CO., LTD. (KR) 2008-06-19 WO disclosed